DowDuPont Merger Heading For Finish Line

Edward Breen (left) is chief executive officer of DuPont and Andrew Liveris (right) is CEO of Dow.

Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now

This audio file is brought to you by

0:00

0:00

Loading audio file, please wait.

Speed
1.00

• 0.25
• 0.50
• 0.75
• 1.00
• 1.25
• 1.50
• 1.75
• 2.00

DuPont (NYSE: DD) and The Dow Chemical Co. (NYSE: DOW) have announced their proposed $130 billion merger has cleared all regulatory approvals and closing conditions. The deal to create DowDuPont will officially close August 31. 

The day after the merger closes, the combined company will begin trading on the New York Stock Exchange under the symbol DWDP. Work will then begin on spinning DowDuPont out into three, independently traded entities, which is expected to take 18 months to complete.

One of the spinoff companies will be an $18 billion ag-focused business that will have a presence in Indianapolis. It will be located in the current Dow Agrosciences facility on the northwest side of Indianapolis.

In May, the companies named the board of directors for DowDuPont. Several senior leadership appointments were announced in May 2016.

Dow Chief Executive Officer Andrew Liveris will become executive chairman of DowDuPont, which will include leading the company’s material science business. DuPont CEO Edward Breen will serve as CEO of DowDuPont’s agriculture and specialty products businesses.